LONDON (Reuters) - AstraZeneca (AZN.L) plans to sign a second deal with an Indian generic drugmaker -- this time for the supply of injectable drugs -- in a further move to boost its emerging market sales, an Indian publication said on Thursday.
LONDON (Reuters) - AstraZeneca (AZN.L) plans to sign a second deal with an Indian generic drugmaker -- this time for the supply of injectable drugs -- in a further move to boost its emerging market sales, an Indian publication said on Thursday.
